Supplements for glioblastoma side effects
As of August 2026, no dietary supplement has demonstrated clinical efficacy in a controlled trial for reducing toxicities specifically related to radiotherapy or temozolomide in WHO grade 4 glioblastoma Verified Answer #2. The current consensus from organizations such as SNO and EANO indicates that the role of nutritional supplements remains unclear due to a lack of well-conducted studies Verified Answer #1.
Supplements with Clinical Signals
While definitive evidence is lacking, two supplements have shown limited positive signals in human studies Verified Answer #1.
Boswellia serrata
- Boswellia serrata or boswellic-acid extract has the strongest evidence base, though it remains of low certainty Verified Answer #1.
- It may reduce treatment-associated cerebral edema as observed on MRI Verified Answer #1.
- A 2025 systematic review of six studies involving 130 patients found that roughly half experienced radiographic or clinical benefits, with one-third reducing long-term dexamethasone use Verified Answer #2.
- However, the data is considered too heterogeneous and prone to bias for formal meta-analysis Verified Answer #2.
Melatonin
- One small, older randomized trial suggested melatonin might lower toxicity related to radiotherapy or steroids Verified Answer #1.
- The evidence for melatonin is limited because the study predates the use of temozolomide and the toxicity outcomes were poorly specified Verified Answer #1.
Management of Supportive Medication Side Effects
Calcium and vitamin D are the only supplements with guideline-backed use for glioblastoma patients, specifically to address complications from dexamethasone rather than chemoradiation Verified Answer #2. Dexamethasone is frequently used to treat peritumoral or radiation edema, but it can lead to glucocorticoid-induced bone loss within three to six months Verified Answer #2. The 2022 ACR guidelines recommend 1,000–1,200 mg/day of calcium and vitamin D for all adults on chronic glucocorticoids to mitigate this risk Verified Answer #2.
Limitations of Current Research
No supplements have demonstrated controlled efficacy for specific temozolomide-associated side effects, including nausea, vomiting, fatigue, constipation, lymphopenia, neutropenia, thrombocytopenia, or hepatotoxicity Verified Answer #1. Evidence for Boswellia is also noted to be drifting away from glioblastoma applications as data remains inconclusive Verified Answer #2.